Carboplatin 450mg
        
            
            
                | Product Overview | 
                        | Generic Name | Carboplatin 450mg | 
                                    | Brand Name(s) | Paraplatin, CARBOplatin, Novaplus | 
                                    | Form | Intravenous injection – sterile aqueous solution, multi-dose vial | 
                                    | Strength | 450 mg /45 mL | 
                                    | Therapeutic Class | Platinum-based antineoplastic alkylating agent | 
                                    | ATC Code | L01XA02 | 
            
            
            
                | Manufacturing & Regulatory | 
                        | Manufacturer | Bristol-Myers Squibb, Pfizer (Paraplatin), Teva, Celon Labs, Fresenius Kabi, Rapid Medico, Onco India, Celon | 
                                    | Country | USA, India, Israel | 
                                    | GMP Compliance | EU/WHO/US FDA/CDSCO | 
                                    | DMF/CEP | Type II/III DMFs requires direct inquiry | 
                                    | COFEPRIS | 010.000.6290.00 | 
                                    | Free Sale Certificate | Yes, Available upon request from GMP‑certified manufacturers | 
            
            
            
                | Logistics & Export | 
                        | MOQ | 25 units | 
                                    | Shelf Life | 36 months | 
                                    | Storage | 15–25 °C; protect from light; amber vials; store in cool dry place | 
                                    | Incoterms | Ex-Works Mexico | 
                                    | Lead Time | 7 to 10 Days | 
            
            
            
                | Documentation | 
                        | Certificate of Analysis (COA) | Yes, upon request | 
                                    | SDS | standard for cytotoxic injectable drugs | 
                                    | CTD Summary | CTD summary/ANDA dossier available upon purchase commitment and NDA/fee | 
            
        
                    
                
Description
                Indications & Usage: Carboplatin is a platinum‑based alkylating chemotherapy agent for ovarian, lung, head/neck, bladder, and germ‑cell tumors. Dosage is calculated by Calvert formula using AUC and GFR; commonly 450 mg IV infusion every 3–4 weeks. Lower nephrotoxicity than cisplatin but notable myelosuppression; hydration and blood‑count monitoring required.            
        
       
            Request for Quote